Editorial: should the inappropriate use of proton pump inhibitors be a quality assurance issue in cirrhotic patients?
Aliment Pharmacol Ther
.
2017 Feb;45(3):476-477.
doi: 10.1111/apt.13875.
Authors
J Shaw
1
,
J S Bajaj
2
Affiliations
1
Department of Medicine, McGuire VA Medical Center, Richmond, VA, USA.
2
Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, VA, USA.
PMID:
28043093
DOI:
10.1111/apt.13875
No abstract available
Publication types
Editorial
Research Support, U.S. Gov't, Non-P.H.S.
Comment
MeSH terms
Humans
Liver Cirrhosis*
Proton Pump Inhibitors*
Risk Factors
Substances
Proton Pump Inhibitors